Related Experiment Video
Updated: Aug 31, 2025

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
Acute Kidney Injury in COVID-19 Patients: Pathogenesis, Clinical Characteristics, Therapy, and Mortality
Venice Chávez-Valencia1, Citlalli Orizaga-de-la-Cruz1, Francisco Alejandro Lagunas-Rangel2
1Department of Nephrology, Hospital General Regional Hospital No. 1, Instituto Mexicano del Seguro Social, Bosque de los Olivos No. 101. Av. La Goleta Mpo. Charo, Morelia 61301, Mexico.
Insights
Coronavirus disease 2019 (COVID-19) frequently causes acute kidney injury (AKI), a serious complication affecting multiple organs. This review examines the pathogenesis, clinical features, therapy, and mortality of COVID-19 associated AKI.
Area of Science:
- Nephrology
- Infectious Diseases
- Virology
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, impacts numerous organs.
- Kidney involvement, specifically acute kidney injury (AKI), is a frequent and severe complication of COVID-19.
- The precise mechanisms underlying SARS-CoV-2-induced kidney damage remain unclear.
Purpose of the Study:
- To review current knowledge on the pathogenesis of COVID-19 AKI.
- To summarize the clinical features, therapeutic strategies, and mortality associated with COVID-19 AKI.
Main Methods:
- Literature review of studies on COVID-19 and acute kidney injury.
- Synthesis of findings on viral pathogenesis, clinical presentation, treatment, and outcomes.
Main Results:
- COVID-19 AKI is a significant complication with variable incidence.
- Multiple factors contribute to COVID-19 AKI, including direct viral effects and systemic inflammation.
- Therapeutic approaches and patient outcomes vary widely.
Conclusions:
- Understanding COVID-19 AKI pathogenesis is crucial for effective management.
- Further research is needed to elucidate mechanisms and optimize treatment strategies.
- COVID-19 AKI significantly impacts patient morbidity and mortality.
Abstract:
Coronavirus disease 2019 (COVID-19) is a disease caused by infection with the SARS-CoV-2 virus and has represented one of the greatest challenges humanity has faced in recent years. The virus can infect a large number of organs, including the lungs and upper respiratory tract, brain, liver, kidneys, and intestines, among many others. Although the greatest damage occurs in the lungs, the kidneys are not exempt, and acute kidney injury (AKI) can occur in patients with COVID-19. Indeed, AKI is one of the most frequent and serious organic complications of COVID-19. The incidence of COVID-19 AKI varies widely, and the exact mechanisms of how the virus damages the kidney are still unknown. For this reason, the purpose of this review was to assess current findings on the pathogenesis, clinical features, therapy, and mortality of COVID-19 AKI.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury VI: Nursing Management

